02/14/2025 8:00 AM | RTW INVESTMENTS, LP (Filed by) SAB Biotherapeutics, Inc. (Subject) SAB Biotherapeutics, Inc. (Subject) SAB Biotherapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025 4:00 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/28/2025 6:11 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/31/2024 4:49 PM | Kropotova Alexandra (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 4:00 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/09/2024 7:21 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2024 4:15 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/08/2024 3:30 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024 7:00 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2024 3:30 PM | Giberson Scott (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:30 PM | Reich Samuel J (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:30 PM | Link David Charles (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:30 PM | HAMILTON CHRISTINE E (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:30 PM | Lucera Erick (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:30 PM | SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) Sullivan Eddie Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:30 PM | SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SKYLER JAY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:30 PM | Polvino William James (Reporting) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:30 PM | SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) Spragens Jeffrey G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 4:29 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/21/2024 6:30 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 4:00 PM | SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics, Inc. (Issuer) SAB Biotherapeutics (Issuer) SKYLER JAY S (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/15/2024 4:15 PM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2024 8:35 AM | SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics, Inc. (Filer) SAB Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |